MedTrace Logo

Study of Vitamin D in the Severely Mentally Ill

NCT01169142 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2018-07-19

No results posted yet for this study

Summary

Supplementation of Vitamin D in those with low levels will increase the level and result in some improvement in health and psychopathology measures.

Conditions

Interventions

DIETARY_SUPPLEMENT

Vitamin D3

50,000 units of Vitamin D3 weekly

DIETARY_SUPPLEMENT

Vitamin D3

Vitamin D3 50,000 units weekly

Sponsors & Collaborators

  • Bronx Psychiatric Center

    lead OTHER_GOV

Principal Investigators

  • NIgel Bark, MD · Bronx Psychiatric Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2014-06-30
Completion
2015-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01169142 on ClinicalTrials.gov